S&P 500   4,282.37 (+1.45%)
DOW   33,762.76 (+2.12%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
S&P 500   4,282.37 (+1.45%)
DOW   33,762.76 (+2.12%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
S&P 500   4,282.37 (+1.45%)
DOW   33,762.76 (+2.12%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
S&P 500   4,282.37 (+1.45%)
DOW   33,762.76 (+2.12%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
NASDAQ:TRIB

Trinity Biotech (TRIB) Stock Forecast, Price & News

$0.98
+0.08 (+8.89%)
(As of 06/2/2023 ET)
Compare
Today's Range
$0.88
$1.00
50-Day Range
$0.84
$1.14
52-Week Range
$0.80
$1.50
Volume
66,821 shs
Average Volume
29,972 shs
Market Capitalization
$37.35 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Trinity Biotech MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.08% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.33mentions of Trinity Biotech in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.22) to $0.14 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.44 out of 5 stars

Medical Sector

908th out of 983 stocks

Diagnostic Substances Industry

13th out of 15 stocks


TRIB stock logo

About Trinity Biotech (NASDAQ:TRIB) Stock

Trinity Biotech Plc engages in the development, manufacture, and marketing of medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market. It operates through the Americas and Rest of World geographical segments. The company was founded by Ronan O'Caoimh and Denis R. Burger in June 1992 and is headquartered in Bray, Ireland.

Receive TRIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter.

TRIB Stock News Headlines

15 A.I. Trading Opportunities a Day
Using our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.
15 A.I. Trading Opportunities a Day
Using our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.
Why Trinity Biotech Stock Is Moving Up Today
See More Headlines

TRIB Price History

TRIB Company Calendar

Last Earnings
3/23/2023
Today
6/02/2023
Next Earnings (Estimated)
6/29/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Diagnostic substances
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:TRIB
Employees
543
Year Founded
1992

Profitability

Net Income
$-41,010,000.00
Pretax Margin
-55.09%

Debt

Sales & Book Value

Annual Sales
$74.78 million
Book Value
($0.06) per share

Miscellaneous

Free Float
34,983,000
Market Cap
$33.92 million
Optionable
Optionable
Beta
1.41

Social Links


Key Executives

  • Aris Kekedjian
    Chairman & Chief Executive Officer
  • John Gillard
    CFO, Secretary & Executive Director
  • Eibhlin Kelly
    Chief Information Officer
  • Terence Dunne
    Director-Business Development
  • Fernando Devia
    Executive Vice President-Sales













TRIB Stock - Frequently Asked Questions

How have TRIB shares performed in 2023?

Trinity Biotech's stock was trading at $0.99 at the beginning of 2023. Since then, TRIB stock has decreased by 10.1% and is now trading at $0.89.
View the best growth stocks for 2023 here
.

Are investors shorting Trinity Biotech?

Trinity Biotech saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 29,400 shares, a decline of 18.3% from the April 30th total of 36,000 shares. Based on an average daily volume of 36,200 shares, the short-interest ratio is presently 0.8 days.
View Trinity Biotech's Short Interest
.

When is Trinity Biotech's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, June 29th 2023.
View our TRIB earnings forecast
.

How were Trinity Biotech's earnings last quarter?

Trinity Biotech plc (NASDAQ:TRIB) posted its earnings results on Thursday, March, 23rd. The company reported ($0.18) earnings per share for the quarter, missing the consensus estimate of ($0.06) by $0.12. The firm earned $18.04 million during the quarter, compared to analysts' expectations of $18 million. Trinity Biotech had a negative net margin of 54.84% and a negative trailing twelve-month return on equity of 724.07%.

What is Ronan O'Caoimh's approval rating as Trinity Biotech's CEO?

20 employees have rated Trinity Biotech Chief Executive Officer Ronan O'Caoimh on Glassdoor.com. Ronan O'Caoimh has an approval rating of 8% among the company's employees. This puts Ronan O'Caoimh in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Trinity Biotech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Trinity Biotech investors own include Gilead Sciences (GILD), Novavax (NVAX), OPKO Health (OPK), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Netflix (NFLX), Pfizer (PFE), QUALCOMM (QCOM), Energy Transfer (ET) and Exxon Mobil (XOM).

What is Trinity Biotech's stock symbol?

Trinity Biotech trades on the NASDAQ under the ticker symbol "TRIB."

Who are Trinity Biotech's major shareholders?

Trinity Biotech's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Hunter Associates Investment Management LLC (4.66%), Renaissance Technologies LLC (3.61%), Aristides Capital LLC (0.43%), Envestnet Asset Management Inc. (0.14%) and Group One Trading L.P. (0.00%).

How do I buy shares of Trinity Biotech?

Shares of TRIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Trinity Biotech's stock price today?

One share of TRIB stock can currently be purchased for approximately $0.89.

How much money does Trinity Biotech make?

Trinity Biotech (NASDAQ:TRIB) has a market capitalization of $33.92 million and generates $74.78 million in revenue each year. The company earns $-41,010,000.00 in net income (profit) each year or ($1.29) on an earnings per share basis.

How many employees does Trinity Biotech have?

The company employs 543 workers across the globe.

How can I contact Trinity Biotech?

Trinity Biotech's mailing address is IDA BUSINESS PARK BRAY, WICKLOW L2, . The official website for the company is www.trinitybiotech.com. The company can be reached via phone at (531) 276-9800, via email at kevin.tansley@trinitybiotech.com, or via fax at 353-1276-9888.

This page (NASDAQ:TRIB) was last updated on 6/2/2023 by MarketBeat.com Staff

My Account -